Hisamitsu Pharmaceutical Co., Inc.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Nov'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Nov 2025 is 10.54% vs -0.15% in Nov 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Nov 2025 is 7.08% vs 22.34% in Nov 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Nov'25",
        "Nov'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "39,571.00",
          "val2": "35,797.00",
          "chgp": "10.54%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "6,221.00",
          "val2": "5,730.00",
          "chgp": "8.57%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "5.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "-196.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "4,990.00",
          "val2": "4,660.00",
          "chgp": "7.08%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "113.20%",
          "val2": "117.70%",
          "chgp": "-0.45%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Feb'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Feb 2025 is 10.09% vs 10.42% in Feb 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Feb 2025 is 54.54% vs 19.01% in Feb 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Feb'25",
        "Feb'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "156,006.00",
          "val2": "141,706.00",
          "chgp": "10.09%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "25,231.00",
          "val2": "18,340.00",
          "chgp": "37.57%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "23.00",
          "val2": "18.00",
          "chgp": "27.78%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-343.00",
          "val2": "-894.00",
          "chgp": "61.63%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "22,301.00",
          "val2": "14,431.00",
          "chgp": "54.54%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "121.10%",
          "val2": "92.90%",
          "chgp": "2.82%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Nov'25 - YoY

Nov'25

Nov'24

Change(%)

Net Sales

39,571.00

35,797.00

10.54%

Operating Profit (PBDIT) excl Other Income

6,221.00

5,730.00

8.57%

Interest

5.00

0.00

Exceptional Items

-196.00

0.00

Consolidate Net Profit

4,990.00

4,660.00

7.08%

Operating Profit Margin (Excl OI)

113.20%

117.70%

-0.45%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Nov 2025 is 10.54% vs -0.15% in Nov 2024

Consolidated Net Profit

YoY Growth in quarter ended Nov 2025 is 7.08% vs 22.34% in Nov 2024

All Quarterly Results

Annual Results Snapshot (Consolidated) - Feb'25

Feb'25

Feb'24

Change(%)

Net Sales

156,006.00

141,706.00

10.09%

Operating Profit (PBDIT) excl Other Income

25,231.00

18,340.00

37.57%

Interest

23.00

18.00

27.78%

Exceptional Items

-343.00

-894.00

61.63%

Consolidate Net Profit

22,301.00

14,431.00

54.54%

Operating Profit Margin (Excl OI)

121.10%

92.90%

2.82%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Feb 2025 is 10.09% vs 10.42% in Feb 2024

Consolidated Net Profit

YoY Growth in year ended Feb 2025 is 54.54% vs 19.01% in Feb 2024

All Annual Results